The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report
- 31 January 2026
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 52, 104070
Abstract
No abstract availableFunding Information
- Healthcare Quality Improvement Partnership
- Heart of England NHS Foundation Trust
This publication has 4 references indexed in Scilit:
- Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE RegistryThe Lancet Regional Health - Europe, 2023
- Estimated Prevalence of Metastatic Breast Cancer in England, 2016-2021JAMA Network Open, 2022
- De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995eClinicalMedicine, 2022
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerAnnals of Oncology, 2021